Dulce Pérez-Figueroa

Prof. Dulce Pérez-Figueroa

Universidad autonoma "Benito Juarez" de Oaxaca
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
IRItayetzi Reyes-Avendaño
Itayetzi Reyes-Avendaño
EREdilburga Reyes-Jiménez
Edilburga Reyes-Jiménez
KGKARINA GONZÁLEZ GARCÍA
KARINA GONZÁLEZ GARCÍA
DPDulce Pérez-Figueroa
Dulce Pérez-Figueroa
RBRafael Baltiérrez-Hoyos
Rafael Baltiérrez-Hoyos
Verónica Rocío Vásquez-GarzónVerónica Rocío Vásquez-Garzón
Verónica Rocío Vásquez-Garzón
Hepatocellular carcinoma (HCC) is a health problem worldwide due to its high mortality rate, and the tumor microenvironment (TME) plays a key role in the HCC progression. The current ineffective therapies to fight the disease still warrant the development of preventive strategies. Quercetin has been shown to have different antitumor activities; however, its effect on TME components in preneoplastic lesions has not been fully investigated yet. Here, we aimed to evaluate the effect of quercetin (10 mg/kg) on TME components during the early stages of HCC progression induced in the rat. Histopathological and immunohistochemical analyses showed that quercetin decreases the size of preneoplastic lesions, glycogen and collagen accumulation, the expression of cancer stem cells and myofibroblasts markers, and that of the transporter ATP binding cassette subfamily C member 3 (ABCC3), a marker of HCC progression and multi-drug resistance. Our results strongly suggest that quercetin has the capability to reduce key components of TME, as well as the expression of ABCC3. Thus, quercetin can be an alternative treatment for inhibiting the growth of early HCC tumors.